Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Cholangiocarcinoma (Phase 2)

Endometrial Neoplasms (Phase 1)

Head and Neck Neoplasms (Phase 2)

Leiomyosarcoma (Phase 2)

Leukemia (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Lymphoid (Phase 1)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 1)

Lymphoma, B-Cell (Phase 1)

Lymphoma, B-Cell, Marginal Zone (Phase 1)

Lymphoma, Follicular (Phase 1)

Lymphoma, Large B-Cell, Diffuse (Phase 1)

Lymphoma, Mantle-Cell (Phase 1)

Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 2)

Proteus Infections (Phase 2)

Proteus Syndrome (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Alveolar Soft Part (Phase 2)

Sarcoma, Clear Cell (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 2)

Waldenstrom Macroglobulinemia (Phase 1)